Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells
Authors:
- Masayuki HosoiMHMasayuki Hosoi
- Hidenori KoyamaaHKHidenori Koyamaa
- Shinji TanakaaSTShinji Tanakaa
- Shinya FukumotoaSFShinya Fukumotoa
- Hirotoshi MoriiaHMHirotoshi Moriia
- Yoshiki NishizawaaYNYoshiki Nishizawaa
- 1 May 2000
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 271 (3) , 571-574
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Immunohistochemical Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Atherosclerotic Intimas of Human Coronary ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Potent Inhibitory Effect of Troglitazone on Carotid Arterial Wall Thickness in Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 1998
- Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty ratsAtherosclerosis, 1998
- Angiogenesis in ischemic heart diseaseNature Medicine, 1997
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.Journal of Clinical Investigation, 1996
- Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limbThe Lancet, 1996
- Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial CellsJournal of Biological Chemistry, 1995
- Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle CellsHypertension, 1995
- Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.Molecular Biology of the Cell, 1992